Akers Biosciences Inc AKERProduct Pipeline Analysis, 2017 Update, Market Outlook, Market Trends: Ken Research
Akers Biosciences Inc (AKER)-Product Pipeline Analysis, 2017 Update

Akers Biosciences Inc (AKER)-Product Pipeline Analysis, 2017 Update

  • Products Id :- GDME282PD
  • |
  • Pages: 43
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary


Akers Biosciences Inc (ABI) is a medical device company that develops, manufactures and supplies point-of-care screening and testing products. The company provides clinical diagnostics, safety diagnostics, and wellness products. Its products include BreathScan, CHUBE, METRON, PIFA PLUSS PF4, tri-cholesterol, PIFA chlamydia, PIFA dengue fever, PIFA malaria, PIFA syphilis, PIFA heparin, and breath ketone. ABI provides testing platform technologies that include MPC biosensor, particle immune-filtration assay, rapid enzymatic assay, minDNA, and synthetic macrocycle complex. The company also offers seraSTAT rapid blood cell separation, a sample preparation technology. ABI is headquartered in West Deptford, New Jersey, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company Akers Biosciences Inc

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Akers Biosciences Inc Company Overview 5

Akers Biosciences Inc Company Snapshot 5

Akers Biosciences Inc Pipeline Products and Ongoing Clinical Trials Overview 5

Akers Biosciences Inc-Pipeline Analysis Overview 8

Akers Biosciences Inc-Key Facts 8

Akers Biosciences Inc-Major Products and Services 9

Akers Biosciences Inc Pipeline Products by Development Stage 10

Akers Biosciences Inc Pipeline Products Overview 12

Breath PulmoHealth Check-COPD 12

Breath PulmoHealth Check-COPD Product Overview 12

Breath PulmoHealth Check-Lung Cancer 13

Breath PulmoHealth Check-Lung Cancer Product Overview 13

BreathScan Asthma 14

BreathScan Asthma Product Overview 14

BreathScan DKA 15

BreathScan DKA Product Overview 15

BreathScan THC 16

BreathScan THC Product Overview 16

Diagnostic Test-Heart Attack 17

Diagnostic Test-Heart Attack Product Overview 17

Handheld Electronic Reader 18

Handheld Electronic Reader Product Overview 18

minDNAnalyzer 19

minDNAnalyzer Product Overview 19

PIFA Chlamydia Rapid Assay 20

PIFA Chlamydia Rapid Assay Product Overview 20

PIFA Hep B / Hep C 21

PIFA Hep B / Hep C Product Overview 21

PIFA HIV 1+2 Rapid Assay 22

PIFA HIV 1+2 Rapid Assay Product Overview 22

PIFA PLUSS-Troponin I 23

PIFA PLUSS-Troponin I Product Overview 23

PIFA PLUSS Hepatitis B Assay 24

PIFA PLUSS Hepatitis B Assay Product Overview 24

PIFA PLUSS Malaria Rapid Assay 25

PIFA PLUSS Malaria Rapid Assay Product Overview 25

Akers Biosciences Inc-Key Competitors 26

Akers Biosciences Inc-Key Employees 27

Akers Biosciences Inc-Locations And Subsidiaries 28

Head Office 28

Other Locations & Subsidiaries 28

Joint Venture 28

Recent Developments 29

Akers Biosciences Inc, Recent Developments 29

May 16, 2017: Akers Biosciences Announces Q1 2017 Earnings 29

Apr 24, 2017: Akers Biosciences Updates on Akers Wellness Tests 30

Apr 11, 2017: Akers Biosciences Reports Earnings for Fiscal Year 2016 31

Apr 11, 2017: Akers Bioscience: Financial Results for the Year Ended December 31, 2016 34

Apr 10, 2017: Akers Biosciences to Commercialize Heparin PF4 Rapid Test in Puerto Rico 35

Mar 30, 2017: Akers Biosciences Reports Preliminary Unaudited Earnings Highlights for Fiscal Year 2016 35

Mar 28, 2017: Akers Biosciences Begins Selling Rapid Cholesterol Test through Distribution Agreement with First Check 37

Feb 16, 2017: Akers Biosciences Allowed US Patent for Akers Wellness Tests Cartridge 37

Feb 01, 2017: Akers Biosciences Announces Trading Update For The Twelve Months Ended December 31, 2016 38

Dec 19, 2016: Akers Biosciences Announces 3-year Agreement with Greater New York Hospital Association for PIFA PLUSS PF4 Rapid Assay 39

Appendix 40

Methodology 40

About GlobalData 42

Contact Us 42

Disclaimer 42

List of Figures

Akers Biosciences Inc Pipeline Products by Equipment Type 6

Akers Biosciences Inc Pipeline Products by Development Stage 10

List of Tables

Akers Biosciences Inc Pipeline Products and Ongoing Clinical Trials Overview 5

Akers Biosciences Inc Pipeline Products by Equipment Type 6

Akers Biosciences Inc Pipeline Products by Indication 7

Akers Biosciences Inc, Key Facts 8

Akers Biosciences Inc, Major Products and Services 9

Akers Biosciences Inc Number of Pipeline Products by Development Stage 10

Akers Biosciences Inc Pipeline Products Summary by Development Stage 11

Breath PulmoHealth Check-COPD-Product Status 12

Breath PulmoHealth Check-COPD-Product Description 12

Breath PulmoHealth Check-Lung Cancer-Product Status 13

Breath PulmoHealth Check-Lung Cancer-Product Description 13

BreathScan Asthma-Product Status 14

BreathScan Asthma-Product Description 14

BreathScan DKA-Product Status 15

BreathScan DKA-Product Description 15

BreathScan THC-Product Status 16

BreathScan THC-Product Description 16

Diagnostic Test-Heart Attack-Product Status 17

Diagnostic Test-Heart Attack-Product Description 17

Handheld Electronic Reader-Product Status 18

Handheld Electronic Reader-Product Description 18

minDNAnalyzer-Product Status 19

minDNAnalyzer-Product Description 19

PIFA Chlamydia Rapid Assay-Product Status 20

PIFA Chlamydia Rapid Assay-Product Description 20

PIFA Hep B / Hep C-Product Status 21

PIFA Hep B / Hep C-Product Description 21

PIFA HIV 1+2 Rapid Assay-Product Status 22

PIFA HIV 1+2 Rapid Assay-Product Description 22

PIFA PLUSS-Troponin I-Product Status 23

PIFA PLUSS-Troponin I-Product Description 23

PIFA PLUSS Hepatitis B Assay-Product Status 24

PIFA PLUSS Hepatitis B Assay-Product Description 24

PIFA PLUSS Malaria Rapid Assay-Product Status 25

PIFA PLUSS Malaria Rapid Assay-Product Description 25

Akers Biosciences Inc, Key Employees 27

Akers Biosciences Inc, Subsidiaries 28

Akers Biosciences Inc, Joint Venture 28

Glossary 41

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com

Akers Biosciences Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license

Single User License
USD 750 INR 50588
Site License
USD 1500 INR 101175
Corporate User License
USD 2250 INR 151763



An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

Ken Research, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@] kenresearch.com